(Q41372677)

30 September 2017

1 reference

title

TNP-470/minocycline/cytotoxic therapy: a systems approach to cancer therapy (English)

1 reference

30 September 2017

B A Teicher

1

1 reference

30 September 2017

Y Emi

series ordinal

2

1 reference

30 September 2017

Y Kakeji

series ordinal

3

1 reference

30 September 2017

D Northey

series ordinal

4

1 reference

30 September 2017

publication date

1 December 1996

1 reference

European Journal of Cancer

30 September 2017

published in

1 reference

30 September 2017

volume

32A

1 reference

30 September 2017

issue

14

1 reference

30 September 2017

page(s)

2461-2466

1 reference

The distribution of secondary growths in cancer of the breast. 1889

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Growth factor targeted and conventional therapy of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

The treatment of amebiasis with fumagillin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Control of nosema disease of honeybees with fumagillin.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Analysis of experimental antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM-1470

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

The influence of angiogenesis inhibitor AGM‐1470 on immune system status and tumor growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Tetracyclines Inhibit Connective Tissue Breakdown: New Therapeutic Implications for an Old Family of Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Reassessment of criteria for the selection of perfluorochemicals for second-generation blood substitutes: analysis of structure/property relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Protection of bone-marrow granulocyte-macrophage colony-forming units in mice bearing in vivo alkylating-agent-resistant EMT-6 tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Effect of hemoglobin solution on the response of intracranial and subcutaneous 9L tumors to antitumor alkylating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

The effect of antisense p120 construct on p120 expression and cell proliferation in human breast cancer MCF-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900380-2

7 January 2021

10.1016/S0959-8049(96)00380-2

Identifiers

DOI

1 reference

30 September 2017

1 reference